Schlagwort: merlin greuel
Are European Life Sciences Startups in Trouble?
Investment in the life sciences sector is facing challenges, with fewer deals and increasing market uncertainty. Despite these difficulties, however, investment volumes are on...
Exploiting market inefficiencies in early-stage biotech investing
One dominant hypothesis in finance is the ‘Efficient Market Hypothesis’ (EMH), which states that the stock price of a security reflects all publicly available...